Overall Performance of a 1-day Silicone Hydrogel Lens When Habitual Soft Lens Wearers Are Refit

February 5, 2019 updated by: CooperVision, Inc.
The objective of the study is to compare the overall subjective comfort profile over 8 hours of lens wear in two groups of habitual soft contact lens wearers (daily disposable hydrogel lenses and frequent replacement lenses) when refitted in to somofilcon A lenses.

Study Overview

Status

Completed

Conditions

Detailed Description

This will be a prospective, single day, randomized, double-masked, non-dispensing, contralateral study. Participants were recruited into one of two groups - participants who habitually wore etafilcon A: daily disposable hydrogel lenses and participants who habitually wore frequent replacement lenses (FREQ).

Study Type

Interventional

Enrollment (Actual)

103

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Waterloo, Canada
        • University of Waterloo
    • Ontario
      • Waterloo, Ontario, Canada, N2L 3G1
        • Center for Contact Lens Research, University of Waterloo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • A person is eligible for inclusion in the study if he/she:

    1. Is at least 17 years of age and has full legal capacity to volunteer;
    2. Has read and signed an information consent letter;
    3. Is willing and able to follow instructions and maintain the appointment schedule;
    4. Is correctable to a visual acuity of 20/40 or better (in each eye) with their habitual correction or the assigned study lenses;
    5. Habitually wears either etafilcon A lens or any frequent replacement contact lenses (as defined in 4.1.1);
    6. Habitually wear contact lenses with a power between -1.00 and -6.00D (Diopters) (inclusive) in both eyes;
    7. Demonstrates an acceptable fit with the study lenses;
    8. Is usually able to wear contact lenses for at least 8 hours per day.

Exclusion Criteria:

  • A person will be excluded from the study if he/she:

    1. Is participating in any concurrent clinical or research study;
    2. Has any known active* ocular disease and/or infection;
    3. Has a systemic condition that in the opinion of the investigator may affect a study outcome variable;
    4. Is using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable;
    5. Has known sensitivity to the diagnostic substances (pharmaceuticals), such as fluorescein dye, or products to be used in the study;
    6. Is aphakic;
    7. Has undergone refractive error surgery.
    8. Has participated in the previous somfofilcon A study (ORE# 20893)

      • For the purposes of this study, active ocular disease is defined as infection or inflammation which requires therapeutic treatment. Mild (i.e. not considered clinically relevant) lid abnormalities (blepharitis, meibomian gland dysfunction, papillae), corneal and conjunctival staining and dry eye are not considered active ocular disease. Neovascularization and corneal scars are the result of previous hypoxia, infection or inflammation and are therefore not active.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Etafilcon A (control)
Subjects in each of the habitual wearing groups will be randomized to wear either the test or control lens in either the left or right eye.
contact lens
contact lens
Active Comparator: Somofilcon A (test)
Subjects in each of the habitual wearing groups will be randomized to wear either the test or control lens in either the left or right eye.
contact lens
contact lens

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comfort
Time Frame: 8 hours
Subjective ratings for lens comfort of etafilcon A and somofilcon A. Scale 0-100, 0=cannot be worn, causes pain, 100=cannot be felt ever.
8 hours
Comfort Preference
Time Frame: Baseline and 8 hours
Lens preference in regards to comfort of etafilcon A and somofilcon A. Categories: Strongly prefer etafilcon A lens, slightly prefer etafilcon A lens, no preference, slightly prefer somofilcon A lens, strongly prefer somofilcon A lens
Baseline and 8 hours
Bulbar Hyperemia
Time Frame: Baseline and 8 hours
Bulbar hyperemia examination using Efron scale 0-4, 0.5 steps, 0=normal, 4=severe.
Baseline and 8 hours
Limbal Hyperemia
Time Frame: Baseline and 8 hours
Limbal hyperemia examination using Efron scale 0-4, 0.5 steps, 0=normal, 4=severe.
Baseline and 8 hours
Conjunctival Staining
Time Frame: 8 hours

Conjunctival staining was graded in each quadrant with scale 0-4, 0.5 steps, 0=normal, 4=severe of four areas:

N - Nasal, T - Temporal, S - Superior, I - Interior, C - Central

8 hours
Visual Acuity
Time Frame: Baseline and 8 hours
High contrast visual acuity at high illumination was measured with each lens at each visit using a logMAR chart.
Baseline and 8 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lyndon Jones, PhD, FCOptom, Centre for Contact Lens Research

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2015

Primary Completion (Actual)

March 1, 2016

Study Completion (Actual)

April 1, 2016

Study Registration Dates

First Submitted

October 22, 2015

First Submitted That Met QC Criteria

October 26, 2015

First Posted (Estimate)

October 28, 2015

Study Record Updates

Last Update Posted (Actual)

February 8, 2019

Last Update Submitted That Met QC Criteria

February 5, 2019

Last Verified

February 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • EX-MKTG-61

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myopia

Clinical Trials on etafilcon A (control)

Subscribe